Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk
dc.contributor.author | Quinney, Sara K. | |
dc.contributor.department | Obstetrics and Gynecology, School of Medicine | en_US |
dc.date.accessioned | 2019-08-30T17:03:23Z | |
dc.date.available | 2019-08-30T17:03:23Z | |
dc.date.issued | 2019-07 | |
dc.identifier.citation | Quinney S. K. (2019). Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk. Clinical pharmacology and therapeutics, 106(1), 72–74. doi:10.1002/cpt.1481 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/20706 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/cpt.1481 | en_US |
dc.relation.journal | Clinical Pharmacology and Therapeutics | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/us | * |
dc.source | PMC | en_US |
dc.subject | Healthcare data | en_US |
dc.subject | Drug‐drug interactions (DDIs) | en_US |
dc.subject | Adverse drug events (ADEs) | en_US |
dc.subject | Bioinformatics | en_US |
dc.title | Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk | en_US |
dc.type | Article | en_US |